Cervidil Articles
Alliance Pharma starts Ph III trial for APL202
17 January 2005
Pharmacia & Paladin sign Canadian distribution deal
28 January 2002
Many US Companies Go Into The Black For 2nd Qtr
5 August 1998
Genetics Institute's Factor IX Approved In 1st Market
17 February 1997
Forest Labs' Cervidil Approved In USA
10 April 1995
FDA YEAR-END DRUG APPROVALS ROLL-OUT
4 January 1993
FREEZES AT UPJOHN IN STRATEGY REVIEW
8 June 1992
UPJOHN UPDATES ON R&D PROGRESS
13 April 1992
Showing 1-8 of 8 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
